Trinity Biotech获得世卫组织批准, 可在岸外制造HIV测试, 从而刺激未来增长。 Trinity Biotech gets WHO approval for offshore manufacturing of its HIV tests, boosting future growth.

Trinity Biotech已获得卫生组织的早期批准,开始在岸外制造其艾滋病毒检测、TrinScreen和Uni-Gold。 Trinity Biotech has received early approval from the WHO to start offshore manufacturing of its HIV tests, TrinScreen and Uni-Gold. 这一批准是公司转型计划的关键一步,预计将促进未来增长、提高利润率和增加股东价值。 This approval is a crucial step in the company's transformation plan and is expected to boost future growth, improve margins, and increase shareholder value. 新离岸设施的制造业定于2025年第一季度开始。 Manufacturing at the new offshore facility is set to begin in the first quarter of 2025.